Zobrazeno 1 - 10
of 755
pro vyhledávání: '"N, Hanson"'
Autor:
Juan G. Ripoll, Sidna M. Tulledge-Scheitel, Anthony A. Stephenson, Shane Ford, Marsha L. Pike, Ellen K. Gorman, Sara N. Hanson, Justin E. Juskewitch, Alex J. Miller, Solomiia Zaremba, Erik A. Ovrom, Raymund R. Razonable, Ravindra Ganesh, Ryan T. Hurt, Erin N. Fischer, Amber N. Derr, Michele R. Eberle, Jennifer J. Larsen, Christina M. Carney, Elitza S. Theel, Sameer A. Parikh, Neil E. Kay, Michael J. Joyner, Jonathon W. Senefeld
Publikováno v:
mBio, Vol 15, Iss 5 (2024)
ABSTRACTAlthough severe coronavirus disease 2019 (COVID-19) and hospitalization associated with COVID-19 are generally preventable among healthy vaccine recipients, patients with immunosuppression have poor immunogenic responses to COVID-19 vaccines
Externí odkaz:
https://doaj.org/article/ecf5af76d7154c2cbf889ff5abdea430
Autor:
Emerson Delacroix, Erika N. Hanson, Sarah Austin, Grant Carr, Kelley M. Kidwell, Jennifer J. Griggs, Elena Martinez Stoffel, Lynette Hammond Gerido, Sarah T. Hawley, Elizabeth Bacon, Ken Resnicow
Publikováno v:
Journal of Men's Health, Vol 19, Iss 12, Pp 23-30 (2023)
This study investigated reasons for lower-than-expected uptake of germline genetic testing compared to national guidelines amongst adult patients with cancer, self-reporting clinician recommendation for genetic testing. Cross-sectional survey of 596
Externí odkaz:
https://doaj.org/article/263ec5e0cf0042079a2d11db1669e53c
Autor:
Erika N. Hanson, Emerson Delacroix, Sarah Austin, Grant Carr, Kelley M. Kidwell, Elizabeth Bacon, Lynette Hammond Gerido, Jennifer J. Griggs, Elena M. Stoffel, Ken Resnicow
Publikováno v:
Cancer Medicine, Vol 12, Iss 8, Pp 9945-9955 (2023)
Abstract Background Only a small proportion of patients who qualify for clinical genetic testing for cancer susceptibility get testing. Many patient‐level barriers contribute to low uptake. In this study, we examined self‐reported patient barrier
Externí odkaz:
https://doaj.org/article/fbaca96cb30943ef9bc2a68325866f71
Autor:
Patrick W. Johnson, BS, Katie L. Kunze, PhD, Jonathon W. Senefeld, PhD, Jorge E. Sinclair, MD, Shahin Isha, MBBS, Parthkumar H. Satashia, MBBS, Shivang Bhakta, MD, Jennifer B. Cowart, MD, Wendelyn Bosch, MD, Jack O’Horo, MD, Sadia Z. Shah, MD, Hani M. Wadei, MD, Michael A. Edwards, MD, Benjamin D. Pollock, PhD, Alana J. Edwards, Sidna Scheitel-Tulledge, MD, Caroline G. Clune, MD, Sara N. Hanson, DO, Richard Arndt, PharmD, Alexander Heyliger, PharmD, Cory Kudrna, MBA, Dennis M. Bierle, MD, Jason R. Buckmeier, BS, Maria Teresa A. Seville, MD, Robert Orenstein, DO, Claudia Libertin, MD, Ravindra Ganesh, MD, Pablo Moreno Franco, MD, Raymund R. Razonable, MD, Rickey E. Carter, PhD, Devang K. Sanghavi, MD, Leigh L. Speicher, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 7, Iss 2, Pp 109-121 (2023)
Objective: To test the hypothesis that the Monoclonal Antibody Screening Score performs consistently better in identifying the need for monoclonal antibody infusion throughout each “wave” of severe acute respiratory syndrome coronavirus 2 (SARS-C
Externí odkaz:
https://doaj.org/article/d8c852a606ff46b89e15c5a2c422bc09
Autor:
Lynette Hammond Gerido, Jennifer J. Griggs, Ken Resnicow, Kelley M. Kidwell, Emerson Delacroix, Sarah Austin, Erika N. Hanson, Elizabeth Bacon, Erika Koeppe, Stefanie Goodall, Matthew Demerath, Elizabeth A. Rizzo, Shayna Weiner, Sarah T. Hawley, Wendy R. Uhlmann, J. Scott Roberts, Elena M. Stoffel
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-13 (2023)
Abstract Background Although most cancers are sporadic, germline genetic variants are implicated in 5–10% of cancer cases. Clinical genetic testing identifies pathogenic germline genetic variants for hereditary cancers. The Michigan Genetic Heredit
Externí odkaz:
https://doaj.org/article/417a4539e1aa4d6d91bc88c232351b10
Autor:
Jose Caleb Quezada Davalos, Michael A. Michaud, Luis E. Lowe, Emily N. Hanson, Eric P. Gaulke, Janel E. Owens
Publikováno v:
Data in Brief, Vol 49, Iss , Pp 109280- (2023)
Per- and polyfluoroalkyl substances (PFAS) are widespread and highly persistent organic chemicals with adverse health effects. The US Environmental Protection Agency has issued health advisory limits of 70 ng/L for aqueous concentrations of PFOA + PF
Externí odkaz:
https://doaj.org/article/b4ff25f3bb3e457aa2d9ceaa92a2fef4
Postacute Sequelae of SARS-CoV-2 Infection—Lessons Learned From a Coordinated Health System Response
Autor:
Ravindra Ganesh, MBBS, MD, Greg S. Vanichkachorn, MD, MPH, Bala Munipalli, MD, Sara N. Hanson, DO, MPH, Abd Moain Abu Dabrh, MBBCh, MS, Ivana T. Croghan, PhD, Nancy L. Dawson, MD, Ryan T. Hurt, MD, PhD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 6, Iss 4, Pp 311-319 (2022)
Objective: To outline a consensus-designed process for triaging and managing patients with post-coronavirus disease (COVID-19) syndrome at Mayo Clinic. Patients and Methods: We convened a central multidisciplinary team including members from the depa
Externí odkaz:
https://doaj.org/article/1d7094e4dd484f12b2c924bff3f86e9c
Autor:
Dennis M. Bierle, Ravindra Ganesh, Caroline G. Wilker, Sara N. Hanson, Darcie E. Moehnke, Tammy A. Jackson, Priya Ramar, Jordan K. Rosedahl, Lindsey M. Philpot, Raymund R. Razonable
Publikováno v:
Journal of Primary Care & Community Health, Vol 12 (2021)
Background The clinical outcomes of patients who decline anti-spike monoclonal antibody therapies for coronavirus disease-2019 (COVID-19) is not known. Factors associated with the decision to accept or decline the offer for anti-spike monoclonal anti
Externí odkaz:
https://doaj.org/article/8c7f9f4327e44a429c67b8685a563a5f
Autor:
Leslie A. Musshafen, Jennifer M. Poger, William R. Simmons, Alicia M. Hoke, Laura N. Hanson, Whitney W. Bondurant, Jody R. McCullough, Jennifer L. Kraschnewski
Publikováno v:
Journal of Clinical and Translational Science, Vol 5 (2021)
Clinical research coordinators are increasingly tasked with a multitude of complex study activities critical to scientific rigor and participant safety, though more than half report not receiving appropriate training. To determine the reproducibility
Externí odkaz:
https://doaj.org/article/9b11be82d0154352a0f94d19b9fd5171
The SRG rat, a Sprague-Dawley Rag2/Il2rg double-knockout validated for human tumor oncology studies.
Autor:
Fallon K Noto, Jaya Sangodkar, Bisoye Towobola Adedeji, Sam Moody, Christopher B McClain, Ming Tong, Eric Ostertag, Jack Crawford, Xiaohua Gao, Lauren Hurst, Caitlin M O'Connor, Erika N Hanson, Sudeh Izadmehr, Rita Tohmé, Jyothsna Narla, Kristin LeSueur, Kajari Bhattacharya, Amit Rupani, Marwan K Tayeh, Jeffrey W Innis, Matthew D Galsky, B Mark Evers, Analisa DiFeo, Goutham Narla, Tseten Y Jamling
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240169 (2020)
We have created the immunodeficient SRG rat, a Sprague-Dawley Rag2/Il2rg double knockout that lacks mature B cells, T cells, and circulating NK cells. This model has been tested and validated for use in oncology (SRG OncoRat®). The SRG rat demonstra
Externí odkaz:
https://doaj.org/article/da40f8be4ff04612b39481863ba9aa2b